Prevention of Capsular Contracture Using Leukotriene Antagonists
Ruth Graf1, Adriana S K Ascenço, Renato da S Freitas
1Curitiba, Paraná, Brazil From the Division of Plastic and Reconstructive Surgery, Hospital de Clínicas, Federal University of Paraná.
Background:
Capsular contracture is a common occurrence in plastic surgery, with a prevalence varying from 0.5 percent up to 30 percent. Although the standard treatment is capsulectomy, alternative treatments have been studied, such as the use of leukotriene inhibitors. These drugs have recently been evaluated in the prophylaxis of contracture. The authors aimed to assess the efficacy of montelukast (Singulair) in the prevention of capsular contracture in patients undergoing mammaplasty with textured silicone prostheses.
Methods:
The authors followed 82 patients (164 breasts) for a minimum of 2 years. Of these, 37 were administered montelukast.
Results:
The number of affected patients and the severity were higher among the 45 patients who did not use montelukast.
Conclusion:
The prophylactic use of Singulair was, in this sample, shown to be effective in helping to reduce the incidence of capsular contracture.
Clinical Question/Level Of Evidence:
Therapeutic, III.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...